The Acceptability of Human Papillomavirus Vaccine among Parents and Guardians of Newborn to 10-year-old Children

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 2, 2011, Pages 66-70

  Gillespie, Laura ^a   Hicks, Caitlin W ^b   Santana, Melissa ^c   Worley, Sarah E ^a   Banas, David A ^d   Holmes, Sumayya ^e   Rome, Ellen S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c HIRAM COLLEGE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e HAMPTON UNIVERSITY   (United States)

Author keywords

Health knowledge, attitudes, practice; Human papillomavirus vaccine; Pediatrics

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CHILD; DOCTOR PATIENT RELATION; DRUG SAFETY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT EDUCATION; PATIENT SATISFACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEXUALITY; STRUCTURED QUESTIONNAIRE; VACCINATION; VIRUS INFECTION; WART VIRUS;

ATTITUDE TO HEALTH; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT; INFANT, NEWBORN; LEGAL GUARDIANS; MALE; PAMPHLETS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; UTERINE CERVICAL NEOPLASMS;

EID: 79952106306     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2010.07.004     Document Type: Article

References (19)

1. Wetzel C., Tissot A., Kollar L.M., et al. Development of an HPV educational protocol for adolescents. J Pediatr Adolesc Gynecol 2007, 20:281.
2. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36:6.
3. Thompson E. " CDC's human papillomavirus and cervical cancer prevention activities." Statement by U.S. Department of Health and Human Services on CDC's Human Papillomavirus (HPV) and Cervical Cancer Prevention Activities. March 3, 2004. Accessed Dec. 13, 2008. http://www.hhs.gov/asl/testify/t040311a.html.
4. Rodriguez A.C., Schiffman M., Herrero R., et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008, 100:513.
5. Lowy D.R., Solomon D., Hildesheim A., et al. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 2008, 113:1980.
6. Barr E., Sings H.L. Prophylactic HPV vaccines: New interventions for cancer control. Vaccine 2008, 26:6244.
7. Chin-Hong P.V., Berry J.M., Cheng S.C., et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008, 149:300.
8. US Food and Drug Administration. " FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus." FDA News Release June 8, 2006. Accessed Sept. 22, 2008. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.
9. Chao C., Slezak J.M., Coleman K.J., et al. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99:1137.
10. Kahn J.A., Ding L., Huang B., et al. Mothers intention for their daughters and themselves to receive the human papillomavirus vaccine: A national study of nurses. Pediatrics 2009, 123:1439.
11. Boehner C.W., Howe S.R., Bernstein D.I., et al. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003, 30:774.
12. Brabin L., Roberts S.A., Farzaneh F., et al. Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine 2006, 24:3087.
13. Davis K., Dickman E.D., Ferris D., et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004, 8:188.
14. Rosenthal S.L., Rupp R., Zimet G.D., et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008, 43:239.
15. Zimet G.D., Mays R.M., Fortenberry J.D. Vaccines against sexually transmitted infections: Promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000, 27:49.
16. Romanowski B., de Borba P.C., et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009, 374:1975. GlaxoSmithKline Vaccine HPV-007 Study Group.
17. David M.P., Van Herck K., Hardt K., et al. Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses. Gynecol Oncol 2009, 115:S1.
18. Gilbert R., Widom C.S., Browne K., et al. Burden and consequences of child maltreatment in high-income countries. Lancet 2009, 373:68.
19. UNESCO Institute for Statistics. Education statistics. 2006;2008(12/13).